Search In this Thesis
   Search In this Thesis  
العنوان
Study Of the different presentations of acute post - streptococcal glomerulonephritis and their relation to the course of the Disease =
الناشر
ِFaculty Of Medicine ,
المؤلف
Ali, Amira Sami Moghazi Mohamed.
الموضوع
Pediatrics.
تاريخ النشر
2010 .
عدد الصفحات
P67. :
الفهرس
Only 14 pages are availabe for public view

from 81

from 81

Abstract

APSGN is an acute reversible disease characterized by spontaneous recovery in the vast majority of patients (95%). It is by far the most common form of glomerulonephritis in children.
Diagnostic features of APSGN include:
A clinically compatible illness, usually with the classical acute nephritic syndrome representing as hematuria, edema, hypertension and / or oliguria, and all three of the following: (74)
1. Dysmorphic RBCs, Acanthocytes ± RBC casts.
2. Reduced serum C3 level < 80mg/dl
3. Evidance of recent group A streptococcal infection, either:
a- A positive throat or skin culture.
b- Elevated ASOT > 200 IU/mL..
c- Elevated anti DNase B> 300U/. mL.
In this study cases with APSGN were 35 male (70%) and 15 female (30%) with a male /female ratio of 2.3:1. Their age ranged from (3- 12) years with a mean age 6.4±2.56 years. The larger population size was within age group (3<6) years.
Data from our study showed that APSGN in children attending AUCH is mainly pharyngitis – associated. History of throat infection could be established in 100% of cases of APSGN. None of the study children had antecedent skin infection.
Our study conducted on 50 cases attending AUCH showed that the clinical presentations were gross hematuria & proteinuria in 100% of cases, oedema in 66%, and hypertension in 44%, oliguria in 14%, ARF in 2 cases (4%), hypertensive encephalopathy in one case ( 2%) with seizures, confusion and coma. While hematuria alone occurred in 22% of cases, the classical nephritic triad (hematutia, hypertension and edema) in 14% of cases. While hemturia, hypertension, edema & oliguria in 6% of cases.
Also as regards urinary changes in children with APSGN; all cases present by hematuria, proteinuria which range from +1(10%) ,+2(62%), +3(28%), granular casts, red cell casts in 50% of cases, dysmorphic RBCs ≥25% with acanthocytes ≥ 5% . 24hrs protein divided into non-nephrotic range in 92%& nephrotic range in 8% of cases. 6% of children presented by complication: Acute renal failure in 4% of cases, hypertensive encephalopathy in 2% of cases but no congestive heart failure among the studied group.
As regards general investigation among our study sample; Ht SDS was normal in 100% of cases, puffy eyelids in 60% of cases, fever in 12% of cases abdominal pain and vomiting in 8% of cases.
It was found that elevation of BUN in 52% of cases , s.creatinine in 40 % of cases and elevation of ASOT in 100% of cases. While low serum C3 level in 100% of cases.
In our study: All cases presented by hematuria, proteinuria, granular casts and dysmorphic RBCs with acanthocytes. RBCs in urine ranged from 50-100 rbcs / HPF with a mean 86.82±17.65 and red cell casts presented in 50% of cases. 24hrs protein ranged from 150-2800 mg/24hrs with a mean of 457.58±514.6 & divided into non - nephrotic range in 92% and nephrotic range proteinuria in 8% of cases. dysmorphic RBCs in urine ranged from 25%-70% with a mean of 39.62± 9.15 and urinary acanthocytes ranged from 5% -10% with a mean 6.52±1.39.
As regard renal ultrasonographic changes among our study showed that it was normal in about 32% of cases and increased corticol echogenicity with normal corticomedullay differentiation in 68%.
Our study showed that resolution of the clinical presentations of cases with APSGN was quite rapid, Blood pressure returned to normal within 1- 4, edema returned within 1-2 weeks, gross hematuria returned within 1-2 weeks, cases with low serum C3 returned to normal within 4-6 weaks, BUN returned within 1-6 weeks, seum creatinine returned within 1-6 weeks, microscopic hematuria returned to normal within 4-6 weeks and gross hematuria within 1-2 weeks.
Much attention is now being paid to the development of streptococcal group A vaccine and studies have already been performed on its preparation, safety and efficacy